Skip to main content
Caplight Logo









Shanghai Stexo Biotechnology Co., Ltd.

Shanghai Stexo Biotechnology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://stexo.com/

Last Round

Pre-D

May 1, 2023

Company Overview

Shanghai Stexo Biotechnology Co., Ltd. is a biotechnology company that develops genetically engineered stem cell-derived exosome therapeutics for the treatment of various medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

exosome therapeuticsextracellular vesicleEVstem cell therapygenetically engineered exosomesbiopharmaceutical R&D3D cell culturecGMP manufacturingregenerative medicinedrug pipelinebiotech platformexosome engineeringcell-free therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Stexo Biotechnology Co., Ltd. Comparables

Compare Shanghai Stexo Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Stexo Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BREXOGEN Inc.
83%
VesiCURE Therapeutics
81%
Beijing Echo Biotech Co., Ltd.
81%

Shanghai Stexo Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre-DMay 1, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2023

    Completed a Pre-D funding round.

Shanghai Stexo Biotechnology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Shanghai Stexo Biotechnology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shanghai Stexo Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Is Shanghai Stexo Biotechnology Co., Ltd. a public or private company?

Shanghai Stexo Biotechnology Co., Ltd. is a private company.

What is the current stock price of Shanghai Stexo Biotechnology Co., Ltd.?

Shanghai Stexo Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Shanghai Stexo Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Shanghai Stexo Biotechnology Co., Ltd. worth (valuation)?

Valuation information for Shanghai Stexo Biotechnology Co., Ltd. is not publicly available.

Can I buy Shanghai Stexo Biotechnology Co., Ltd. stock?

Shanghai Stexo Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Shanghai Stexo Biotechnology Co., Ltd.'s last funding round?

Shanghai Stexo Biotechnology Co., Ltd.'s most recent funding round was Pre-D on May 1, 2023.

Who are the main investors in Shanghai Stexo Biotechnology Co., Ltd.?

Investor information for Shanghai Stexo Biotechnology Co., Ltd. is not publicly disclosed.

Will Shanghai Stexo Biotechnology Co., Ltd. IPO soon?

No public IPO plans have been announced for Shanghai Stexo Biotechnology Co., Ltd..

How can I track Shanghai Stexo Biotechnology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Stexo Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2023
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?